| Application no. and date | 19214560.5 (espacenet) (Federated) (European Patent Register), 20141223 | | Patent/reg. no. and date | DK/EP 3639828, 20211201 | | Publication date | 20200422 | | Priority no. and date | US 201361920617 P, 20131224 | | EP pub. no. and date |
EP 3639828 20200422 | | Effective date | | | Applicant/owner | Durect Corporation, 10260 Bubb Road
Cupertino, CA 95014, US,
Virginia Commonwealth University, 800 East Leigh Street
Suite 3000
Richmond, VA 23298, US,
The United States Government as Represented by
The Department of Veterans Affairs, 810 Vermont Avenue, N.W.
Washington, DC 20420, US | | Applicant ref. no. | V437649DK00 | | Inventor | REN, Shunlin, 1201 Broad Rock Boulevard
Research 151
Richmond, VA Virginia 23249, US,
THEEUWES, Felix, 27350 Altamont Road
Los Altos Hills, CA California 94022, US,
BROWN, James E., 126 Blueberry Hill Drive
Los Gatos, CA California 95032, US,
LIN, WeiQi, 590 California Way
Emerald Hills, VA Virginia 94062, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/56 (2006.01) , A61K 31/568 (2006.01) , A61K 31/575 (2006.01) , A61K 35/12 (2015.01) , A61P 1/16 (2006.01) , A61P 43/00 (2006.01) | | Title | Anvendelse af oxygenerede cholesterolsulfater (OCS) til behandling af akut leversvigt | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
